Ferronova is a cancer diagnostics company, developing magnetic probe and tracer systems for improved lymph node identification.
More than 40% of people will be diagnosed with cancer during their lifetime. Successful cancer treatment relies on accurate staging of how far, and where cancer has spread from a primary tumour. The lymphatic system is the primary pathway for the spread of most cancers.
Ferronova’s system, consisting of a magnetic probe and injectable magnetic tracers, is able to less invasively, more quickly, and more accurately stage the spread of cancer resulting in: